Back to SUSQUEHANNA INTERNATIONAL GROUP, LLP SUSQUEHANNA INTERNATIONAL GROUP, LLP

MRNSMRNS
Showing 3 of 19 quarters

Position history for SUSQUEHANNA INTERNATIONAL GROUP, LLPSUSQUEHANNA INTERNATIONAL GROUP, LLP's holdings in MARINUS PHARMACEUTICALS INC

As of its Q4 2024 13F, Susquehanna International Group held 100,853 shares of MRNS (Marinus Pharmaceuticals), worth $53,966. Susquehanna International Group's 13F filings listed MRNS from Q3 2020 to Q4 2024, 18 quarterly filings.

Final Value

$0

Final Shares

0

Total Value Change

-$130,027

Total Shares Change

-73,879

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2025-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2024-Q4
Increased
100,853
+36.5%
$53,9660.0%—
18
2024-Q3
Decreased
73,879
-85.3%
$130,0270.0%—
0

Other major holders of MRNS: Avoro Capital Advisors LLC, BlackRock Finance, Inc., FRANKLIN TEMPLETON INC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used